Literature DB >> 12405259

Development of a simple and sensitive technique for detection of point mutations in the K-ras oncogene.

C Fernández-Vega1, D C García-Olmo, M A Ballesteros, D García-Olmo.   

Abstract

We sought to develop a simple and sensitive method based on mutant allele-specific amplification (MASA) for the detection of point mutations in the k-ras oncogene in blood samples. We used MASA and three nested MASA methods to detect a point mutation (GGT-->GAT) in rat DHD cells at codon 12 of exon 1 of the k-ras gene. MASA allowed us to detect one k-ras mutated cell on a background of 10(7) normal cells. The third nested-MASA (nested-MASA.c) method that we developed allowed us to detect one mutated cell among 10(10) normal cells. Our methods should allow the detection of small amounts of mutant k-ras DNA in tissue, serum, and plasma, combining speed with efficiency and specificity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12405259     DOI: 10.1385/MB:22:2:115

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  16 in total

1.  Horizontal transfer of DNA and the "genometastasis hypothesis".

Authors:  D García-Olmo; D C García-Olmo; J Ontañón; E Martinez
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

Review 2.  ras oncogenes: their role in neoplasia.

Authors:  M Barbacid
Journal:  Eur J Clin Invest       Date:  1990-06       Impact factor: 4.686

3.  Prognostic value of genetically diagnosed lymph node micrometastasis in non-small cell lung carcinoma cases.

Authors:  T Hashimoto; Y Kobayashi; Y Ishikawa; S Tsuchiya; S Okumura; K Nakagawa; Y Tokuchi; M Hayashi; K Nishida; S Hayashi; J Hayashi; E Tsuchiya
Journal:  Cancer Res       Date:  2000-11-15       Impact factor: 12.701

4.  Adenocarcinoma arising in gastric heterotopic pancreas: clinicopathological and immunohistochemical study with genetic analysis of a case.

Authors:  M Osanai; N Miyokawa; T Tamaki; M Yonekawa; A Kawamura; N Sawada
Journal:  Pathol Int       Date:  2001-07       Impact factor: 2.534

5.  Clinical significance of K-Ras mutations in intraoperative tumor drainage blood from patients with colorectal carcinoma.

Authors:  T Etoh; H Ueo; H Inoue; K Sato; T Utsunomiya; G F Barnard; S Kitano; M Mori
Journal:  Ann Surg Oncol       Date:  2001-06       Impact factor: 5.344

Review 6.  Molecular assays for the diagnosis of minimal residual head-and-neck cancer: methods, reliability, pitfalls, and solutions.

Authors:  V M van Houten; M P Tabor; M W van den Brekel; F Denkers; R G Wishaupt; J A Kummer; G B Snow; R H Brakenhoff
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

7.  K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: diagnostic utility and prognostic significance.

Authors:  A Castells; P Puig; J Móra; J Boadas; L Boix; E Urgell; M Solé; G Capellà; F Lluís; L Fernández-Cruz; S Navarro; A Farré
Journal:  J Clin Oncol       Date:  1999-02       Impact factor: 44.544

8.  Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells.

Authors:  A Zippelius; R Lutterbüse; G Riethmüller; K Pantel
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

9.  K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma.

Authors:  H Watanabe; A Ha; Y X Hu; K Ohtsubo; Y Yamaguchi; Y Motoo; T Okai; D Toya; N Tanaka; N Sawabu
Journal:  Cancer       Date:  1999-10-15       Impact factor: 6.860

10.  Detection of tumour DNA in serum of colorectal cancer patients.

Authors:  J B de Kok; W W van Solinge; T J Ruers; R W Roelofs; G N van Muijen; J L Willems; D W Swinkels
Journal:  Scand J Clin Lab Invest       Date:  1997-11       Impact factor: 1.713

View more
  1 in total

Review 1.  Clinical relevance of KRAS in human cancers.

Authors:  Sylwia Jancík; Jirí Drábek; Danuta Radzioch; Marián Hajdúch
Journal:  J Biomed Biotechnol       Date:  2010-06-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.